{
  "docId": "019de511-116c-769a-af30-00a56112ffbd",
  "docSlug": "6dbbbde9942752c16f9f4678dff28ed3",
  "documentTitle": "Nyxoah | IPO Presentation Deck | 34 slides",
  "authorId": "nyxoah",
  "authorName": "Nyxoah",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7794254,
  "pageNumber": 3,
  "pageCount": 34,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "appendix_data",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 4,
  "notes": "Includes specific details on shares offered, underwriter options, insider participation, and use of proceeds.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de511-116c-769a-af30-00a56112ffbd/3",
  "deckHref": "/decks/019de511-116c-769a-af30-00a56112ffbd",
  "deckJsonHref": "/decks/019de511-116c-769a-af30-00a56112ffbd.json",
  "deckAnchorHref": "/decks/019de511-116c-769a-af30-00a56112ffbd#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.85,
        "x": 0.03,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "1. Cochlear Investments Pty. Ltd. and Resmed Inc. have indicated an interest in purchasing an aggregate of up to approximately $34 million in ordinary shares at the public offering price.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7c81b19e-a405-45e3-8aa2-9525197772d7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.75,
        "w": 0.94,
        "x": 0.03,
        "y": 0.15
      },
      "kind": "table",
      "text": "Issuer: Nyxoah SA; Exchange/Ticker: Nasdaq/NYXH; Shares Offered: 2,760,000; Security type: Ordinary shares; Underwriter's Option: 15%; Insider Participation: Cochlear Investments, Resmed; Use of Proceeds: Commercialization, R&D, Working Capital",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9a9c7983-1471-4b0d-ac4a-09a34b1297a1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.2,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "Offering Summary",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a79daf62-3783-46bb-a910-6dd1991b6c31",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}